Physician profile
Derek Eugene Andreini
NPI 1568923167
$6,809.89
in general payments reported to CMS, 2019-2025
10 companies · $3,776 in 2025
The $3,776 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,034 · 2025: $3,776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,610 · Grant: $2,000 · Travel and Lodging: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,610.35 |
| Grant | $2,000.00 |
| Travel and Lodging | $1,199.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,436.04 | 2024-2025 | Mako, Insignia, Triathlon |
| Smith+Nephew, INC. | $2,000.00 | 2024-2025 | |
| Innovation Technologies INC | $464.09 | 2024-2025 | Irrisept |
| Depuy Synthes Sales INC. | $304.65 | 2024 | Na, Attune, Va-Lcp |
| Zimmer Biomet Holdings, INC. | $277.29 | 2024-2025 | Persona, Rosa, Oxford |
| Integra Lifesciences Corporation | $171.64 | 2024 | Tenoglide |
| Medtronic, INC. | $83.90 | 2024 | Aquamantys(Tm) |
| Medical Device Business Services, INC. | $25.43 | 2024 | Attune |
| Bioventus LLC | $25.06 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $21.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Andreini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.